TITLE

Reply to Lundgren et al

AUTHOR(S)
Wilkin, Timothy J.; Gulick, Roy M.
PUB. DATE
April 2009
SOURCE
Clinical Infectious Diseases;4/15/2009, Vol. 48 Issue 8, p1162
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to the article "Uncertainty As to Whether the Use of Antiretroviral Therapy for Persons Recently Infected With HIV Has a Favorable Risk-to-Benefit Ratio," by J. D. Lundgren, A. N. Phillips and J. Neaton in the 2009 issue.
ACCESSION #
37828132

 

Related Articles

  • Perinatal HIV and Option B+. Theron, Gerhard // South African Journal of Obstetrics & Gynaecology;Oct2012, Vol. 18 Issue 3, p66 

    An introduction is presented in which the editor discusses various reports within the issue on topics including the minimal access to antiretroviral therapy (ART), meta-analysis and systematic review of efavirenz (EFV) safety, and in vitro exposure of infants to antiretrovirals (ARVs).

  • partial suppressor:. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p172 

    A definition of the term "partial suppressor," which refers to an individual taking highly active antiretroviral therapy whose viral load sometimes rises above the undetectable level, is presented.

  • Focal adenitis developing after immune reconstitution with HAART. Price, Lynn M.; O'Mahony, Colm; Price, L M; O'Mahony, C // International Journal of STD & AIDS;Oct2000, Vol. 11 Issue 10, p685 

    A letter to the editor is presented focusing on the success of highly active antiretroviral therapy (HAART) in unmasking previously subclinical Mycobacterium avium-intracellulare infection.

  • Exacerbation of hepatitis B infection following cessation of lamivudine therapy. Barlow, G. D.; France, A. J. // International Journal of STD & AIDS;Oct2000, Vol. 11 Issue 10, p684 

    A letter to the editor is presented focusing on the importance of exercising caution when considering HIV and hepatitis B co-infected patients for treatment with highly active antiretroviral therapy.

  • In HIV-infected patients, some differential alterations of CD4 and CD8 T cell homeostasis may not be restored by ≥7 years of highly active antiretroviral therapy, in spite of good CD4 T cell repopulation. Bordoni, Veronica; Agrati, Chiara; Rinaldi, Alessandra; Viola, Domenico; De Simone, Gabriele; Gioia, Cristiana; Martini, Federico // Journal of Antimicrobial Chemotherapy (JAC);Jul2012, Vol. 67 Issue 7, p1802 

    A letter to the editor is presented in response to the article by Méndez-Lagares et al. on the alterations in T cell homeostasis in patients on highly active retroviral therapy (HAART), which appeared in a 2012 issue.

  • Treatment and CD4+ T Cell Count Recovery among Antiretroviral Therapy-Naive Patients with HIV/AIDS. Naggie, Susanna; Tsung Hseih; Reckleff, Jennifer; Castellano, Joe; Hicks, Charles B. // Clinical Infectious Diseases;11/15/2009, Vol. 49 Issue 10, p1619 

    A letter to the editor is presented in response to the article about the use of initial antiretroviral therapy (ART) for treatment of native patients with HIV or AIDS.

  • Does Contrast Enhancement Predict Survival in Progressive Multifocal Leukoencephalopathy? Focosi, Daniele // Journal of Infectious Diseases;5/1/2009, Vol. 199 Issue 9, p1410 

    A letter to the editor is presented in response to a previously published article concerning the use of the lack of contrast enhancement on computed tomography (CT) or magnetic resonance imaging (MRI) scans to identify patients with progressive multifocal leukoencephalopathy (PML).

  • Reply to Focosi. Engsig, Frederik Neess; Hansen, Ann-Brit Eg; Omland, Lars Haukali; Kronborg, Gitte; Gerstoft, Jan; Laursen, Alex Lund; Pedersen, Court; Mogensen, Christian Backer; Nielsen, Lars; Obel, Niels // Journal of Infectious Diseases;5/1/2009, Vol. 199 Issue 9, p1411 

    A response by Frederik Neess Engsig and colleagues to a letter to the editor about their article concerning the use of the lack of contrast enhancement on computed tomography (CT) or magnetic resonance imaging (MRI) scans to identify patients with progressive multifocal leukoencephalopathy (PML).

  • Effectiveness and safety of 30 mg versus 40 mg stavudine regimens: a cohort study among HIVinfected adults initiating HAART in South Africa. Maskew, Mhairi; Westreich, Daniel; Fox, Matthew P.; Maotoe, Thapelo; Sanne, Ian M. // Journal of the International AIDS Society;2012, Vol. 15 Issue 1, p1 

    Background: As stavudine remains an important and widely prescribed drug in resource-limited settings, the effect of a reduced dose of stavudine (from 40 mg to 30 mg) on outcomes of highly active antiretroviral therapy (HAART) remains an important public health question. Methods: We analyzed...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics